BCAB BioAtla, Inc.
NEUTRAL
Impact: 4/10
DEFA14A
Proxy solicitation materials
Final — all horizons settled through T+60d ⚠ clustered
BCAB ▼ -61.67% at T+60d
NEUTRAL call ✗ call lost -61.67% · α vs SPY -70.99% · entry $10.20 → $3.91
Last close $3.86 (close Jun 12) · -62.16% from $10.20 entry
T+1d
-9.31%
call -9.31% · α -8.40%
$9.25
settled 3mo ago
T+5d
-7.35%
call -7.35% · α -6.15%
$9.45
settled 3mo ago
T+20d
-24.51%
call -24.51% · α -16.57%
$7.70
settled 3mo ago
T+60d
-61.67%
call -61.67% · α -70.99%
$3.91
settled 19d ago
Price Chart
Loading chart...
Executive Summary
BioAtla is holding a special shareholder meeting to approve a merger with its wholly-owned subsidiary. The merger agreement was amended to ensure brokers can vote shares held in street name, addressing a prior quorum issue. The board unanimously recommends approval.
Actionable Insight
Monitor for shareholder vote outcome and potential stock price movement around the merger approval date. Watch for any activist opposition despite board support.
Key Facts
- Special meeting scheduled for March 23, 2026 to approve merger with wholly-owned subsidiary BA Merger Sub, Inc.
- Merger agreement amended to keep company's certificate of incorporation unchanged, allowing broker voting on shares held in street name.
- Amendment addresses quorum issue from previous meeting where brokers couldn't vote on non-routine proposals.
- Board unanimously recommends voting FOR both merger and adjournment proposals.
- Approval requires majority of outstanding shares.
Financial Impact
No financial figures provided in filing
Risk Factors
- Failure to achieve quorum or majority approval could delay or derail the merger
- Potential for shareholder dissent despite board recommendation
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001539497-26-000813 |
| Document: 0001539497-26-000813-index-headers.html | 0001539497-26-000813 |
| Document: 0001539497-26-000813-index.html | 0001539497-26-000813 |
| Document: 0001539497-26-000813.txt | 0001539497-26-000813 |
3 reports for BCAB
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Mar 31, 2026
10w ago
|
8-K
| $6.75 $4.04 | ▲ +40.15% | ▲ +49.87% | $3.86 (+42.81%) |
|
Mar 2, 2026
14w ago
|
DEFA14A
| $10.20 $7.70 | ▼ −24.51% | ▼ −16.57% | $3.86 (−62.16%) |
|
Mar 2, 2026
14w ago
|
Press Release
| $10.20 $7.70 | ▲ +24.51% | ▲ +16.57% | $3.86 (+62.16%) |
Showing 3 of 3
US Market Status
Market Closed — Opens in 5h 9m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access